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Approximately 2 to 3 million people in the United States suffer from chronic
wounds, which are defined as wounds that do not heal in 30 days time; an estimated
$25 billion per year is spent on their treatment in the United States. In our work,
we focused on treating chronic wounds with bacterial infections using hyperbaric
and topical oxygen therapies.
We used a mathematical model describing the interaction between bacteria,
neutrophils and oxygen. Optimal control theory was then employed to study oxygen
treatment strategies with the mathematical model. Existence of a solution was
shown for both therapies. Uniqueness was also shown for hyperbaric therapy. We
then used a forward-backward sweep method to find numerical solutions for the
therapies. We concluded by putting forth ideas for how this problem could progress
toward finding applicable treatment strategies.
ix
I. INTRODUCTION
Introduction: Biology
The skin is the largest organ in the body; it has six primary functions
(protection, sensation, thermoregulation, excretion, metabolism, and body image).
When skin is damaged and a wound is formed, it undergoes three main phases of
healing: inflammation, proliferation, and remodeling (Diegelmann & Evans, 2004;
Thackham et al., 2008). These phases overlap providing a cascade of wound-healing
events. The main functions of the inflammatory phase is to control bleeding, remove
debris, and prepare for new tissue by killing bacteria and redirecting blood flow
(Brown et al., 2001). There are two parts of this phase, hemostasis and
inflammation. Hemostasis only lasts a few hours and its purpose is to control
bleeding through vasoconstriction, thromboplastin production and clot formation
(Broderick, 2009). After bleeding is controlled, the inflammation part of this phase
begins. The inflammatory phase is characterized by pain, redness, swelling and
heat, normally lasting 1-to-4 days post injury. Neutrophils are the first of the
inflammatory cells to arrive at the wound and begin removing debris and killing
bacteria. Following neutrophils, monocytes are introduced into the wound and
become activated macrophages. They convert macromolecules into amino acids and
sugars necessary for wound healing. Macrophages also produce chemoattractants
(enzymes that stimulate angiogenesis, fibroblasts, and growth factors), which
attract cells needed for new tissue growth. The main function of the proliferation
phase is to deposit connective tissue and crosslink collagen (Brown et al., 2001).
There are two parts to this phase, granulation and epithelialization. Granulation
refers to the dermal layer of skin and epithelialization the epidermal layer of skin.
After debris is removed from the wound, granulation tissue, which is comprised of
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macrophages, fibroblasts, extracellular matrix (including immature collagen), blood
vessels, and ground substance (water, electrolytes, and plasma proteins), fill the
wound. Angiogenesis, the creation of new blood vessels by endothelial cells from
existing ones, is stimulated by the need to create a blood supply (Broderick, 2009).
Epithelialization begins after the wound is filled with granulation tissue as epithelial
cells, through a process called “contact guidance”, begin to seal the wound (Hess,
2002). This is similar to a pond freezing from the outside into the center (Broderick,
2009). A scar forms when this phase is complete, usually within 4 to 20 days post
injury. The remodeling phase occurs as collagen fibers are strengthened and
reorganized. It increases the tensile strength of the granulation tissue and the
wound continues to contract. The scar continues to shrink and becomes paler and
thinner. The new skin only has about 80% of the tensile strength of normal skin
(Brown et al., 2001).
Two ways to categorize wounds are acute and chronic. Acute wounds follow
the wound-healing stages described above. They heal at a predictable rate and
manner. Chronic wounds begin as acute wounds but do not progress through the
normal stages of healing. They do not heal within a reasonable amount of time,
defined to be more than 30 days. The most common chronic wounds are lower
extremity ulcers. Chronic venous insufficiency (CVI) accounts for 80% to 90% of
lower extremity ulcers and affects 2% to 5% of the population. The cost of treating
CVI ulcers alone is estimated at $1 billion/year in the United States (Broderick,
2009). An estimated $25 billion/year is spent in the United States for the treatment
of chronic wounds (Sen et al., 2009) and approximately 2 to 3 million people suffer
from them in the United States. Improving the healing response of chronic wounds
could significantly reduce the cost of treatment (Kuehn, 2007; Broderick, 2009).
Chronic wounds often remain in a prolonged inflammatory state (Broderick,
2009). There are many reasons for a wound not to heal properly. Factors impacting
2
healing include: underlying conditions such as diabetes mellitus, immunodeficiencies
or infection, aging (the elderly have a higher percentage of chronic illnesses), oxygen
availability to the wound, nutrition, age of the wound, bioburden (number of
bacteria in the wound), and stressors (Broderick, 2009). When a chronic wound is
unable to heal in a reasonable time frame, additional treatment strategies are
necessary to produce a successful healing response. These therapies can include
hyperbaric and topical oxygen, electrical stimulation, hydrotherapy, ultrasound,
nutritional support, compression (elastic stockings or bandaging for lower
extremities), support surfaces (cushions, mattresses, etc.) and topical growth factors
(Hess, 2002).
One reason chronic wounds do not progress to the proliferation phase is that
inflammatory cells, like neutrophils, struggle to remove bacteria from the wound.
This is due, in part, to a lack of oxygen in the wound. Inflammatory cells and
macrophages require adequate tissue oxygenation to kill bacteria in the wound as
they convert oxygen to reactive oxygen species, which is toxic to bacteria (Roy et
al., 2009). Decreased oxygen availability also impacts collagen formation,
angiogenesis, and epithelialization (Broderick, 2009), as well as the control of
infection (Morison et al., 1997).
In our work, we will focus on treating chronic wounds with bacterial
infections using various oxygen therapies. Two methods of delivering supplemental
oxygen to a wound are hyperbaric and topical oxygen therapies (Thackham et al.,
2008; Gordillo & Sen, 2009). During hyperbaric oxygen therapy, patients are placed
in pressurized chambers where they breathe 100% oxygen at 2-3 atmospheres of
pressure for 1-2 hours per session (Thackham et al., 2008; Gordillo & Sen, 2009).
Treatment is usually administered once or twice per day for five days per week for
2-6 weeks, depending on the severity of the wound. Hyperbaric therapies can be
administered in two ways - a monoplace chamber or a multiplace chamber. The
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monoplace chamber administers oxygen systemically through the vascularized
system and topically by placing the person in a full body chamber where their
whole body is surrounded by pure oxygen. The multiplace chamber administers
oxygen systemically by only breathing the pure oxygen (Geris et al., 2010).
Hyperbaric oxygen has been shown to significantly reduce the number of
amputations (Faglia et al., 1996).
Topical oxygen therapy is typically administered by attaching an inflatable
device around the wound region that delivers 100% oxygen to the wound at or
slightly above 1 ATM of pressure for about 90 minutes each session once per day for
about four days followed by three days of rest with no treatment. This process is
continued until the wound has ideally healed (Gordillo et al., 2003; Rodriguez et al.,
2008; Gordillo & Sen, 2009). The greatest benefit of topical oxygen therapy is seen
in tissues with compromised blood flow (Hess, 2002).
Introduction: Mathematical Modeling
Over the past 20 years, mathematical modeling of the wound-healing process
has been an active area of research (Schugart et al., 2008; Thackham et al., 2008).
Recent mathematical models have focused on analyzing treatment strategies (Geris
et al., 2010). One area of mathematics that analyzes the decision-making process is
optimal control theory. To date, optimal control theory has not been used to
analyze treatment strategies in wound healing. However, optimal control theory has
been used to study problems in biology, including cancer and HIV modeling (Fister,
et al., 1998; Fister & Panetta, 2003; Lenhart & Workman, 2007). The purpose of
this work is to use optimal control theory in order to analyze oxygen therapy on the
treatment of a bacterial infection in a wound.
We will use a model originally developed by Schugart and Joyce to model the
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interaction between bacteria, neutrophils, and oxygen. Their model in
non-dimensionalized form is:
db
dt
= kbb (1− b)− bknrn+ δ
λrbb+ 1
∗ w
w + kw
− λbb (1)
dn
dt
= kpe
−λpt(1− n) + knibn(1− n)gnw(w)
λnin+ 1
− λnn
1 + eb
(2)
where gnw(w) =
 2w
3 − 3w2 + 2 for 0 ≤ w < 1,
1 for w ≥ 1
dw
dt
= β + γ ∗ u(t)− λww − λbwbw − λnwnw (3)
n(0) = 0, b(0) = binit, w(0) = winit,
where b denotes the density of bacteria, n denotes the level of neutrophils, and w
denotes the oxygen concentration in the wound.
In the
db
dt
equation, the first term kbb(1− b) represents the bacterial
proliferation using a logistic growth term. The second term −bknrn+ δ
λrbb+ 1
∗ w
w + kw
models oxidative killing of bacteria. The last term −λbb represents the loss of
bacteria due to natural death. The first term of the
dn
dt
equation kpe
−λpt(1− n)
models the activation of the neutrophils. The second term
knibn(1− n)gnw
λnin+ 1
describes the recruitment of the neutrophils while the third term − λnn
1 + eb
represents
the death of neutrophils. The third differential equation models the change in
oxygen. β represents the amount of oxygen that diffuses into the system from the
surrounding blood vessels and γ ∗ u(t) represents the external input of oxygen scaled
by gamma. The terms −λbwbw − λnwnw, describe the uptake of oxygen by bacteria
and inflammatory cells, respectively, and −λww represents the decay of oxygen. The
u is our control variable and it represents the input of oxygen.
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Introduction: Optimal Control Theory
Optimal control theory allows us to make decisions about complex biological
situations when we adjust a control variable. State variable(s) describe the behavior
of the underlying dynamical system. We can change the behavior of the state
variable(s) by adjusting the control function(s). The goal is to maximize or
minimize a prescribed objective functional.
As in Lenhart and Workman (2007), to define the control set for given
a, b, t1 > 0, let
U ≡ {u(t) : a ≤ u(t) ≤ b, t0 ≤ t ≤ t1, u(t) is Lebesque measurable.} (4)
The changes in the state ~x(t) ∈ Rn, under a given control u ∈ U, are determined by
a system of ordinary differential equations:
~x′(t) = ~g(t, x, u),
~x(0) = ~x0, and ~x(t1) free;
(5)
where the basic optimal control problem consists of finding a piecewise continuous
control u(t) and the associated state variable ~x(t) to minimize (or maximize) the
given objective functional:
J [u] = min
a≤u≤b
∫ t1
t0
f(t, x(t), u(t)) dt
which may also be written as:
J [u∗] = min
u∈U
J [u]
subject to the above state system (5) where u∗ represents the optimal state of U .
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The ~x(t1) free term means that the value ~x(t1) is unrestricted, where f and g are
continuously differentiable functions in all three arguments. Thus, the control(s)
will be piecewise continuous and the state variables will be piecewise differentiable.
Necessary conditions are derived using Pontryagin’s Maximum Principle
which is given in Theorem I.1 from Lenhart and Workman (2007). See Appendix A
for more details.
Theorem I.1. For the control ~u = (u1, ..., um)
ᵀ belonging to the admissible control
set U and related trajectory ~x = (x1, ..., xn)
ᵀ that satisfies
d~x
dt i
= gi(~x, ~u, t) (state equations),
~xi(a) = ci (initial conditions)
but with free end conditions, to minimize the performance criterion
J = φ(~x, t)|ba +
∫ b
a
f(~x, ~u, t)dt
it is necessary that a vector ~λ = ~λ(t) exists such that
d~λi
dti
= −∂H
∂~xi
(adjoint equations),
~λi(b) = φxi [~x(b), b] (adjoint final conditions),
where the Hamiltonian
H(t, ~x, u) = f(t, ~x, u) + λᵀ ∗ ~g(t, ~x, u),
= integrand+ adjoint ∗RHSofDE
for all t, a ≤ t ≤ b, and all ~u ∈ U , satisfies
H[~λ(t), ~x∗(t), ~u] ≥ H[~λ(t), ~x∗(t), ~u∗].
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Adjoint functions are similar to Lagrange multipliers because they add
constraints to variables being maximized or minimized.
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II. NON-LINEAR CONTROL
Forming the Hamiltonian for Non-linear Control
The objective functional J [u(t)] for the nonlinear control is
J [u(t)] =
∫ t1
0
[
b(t) +
c
2
u2(t)
]
dt
where 0 ≤ u ≤M2.
(6)
This models supplemental oxygen administered in the wound through
hyperbaric oxygen therapy. A nonlinear function is reasonable because it is unlikely
the body is systematically processing the oxygen in a linear way. We use the
differential equations (1-3) from Schugart and Joyce. The Hamiltonian for the
non-linear control without bounds is:
H = b+
c
2
u2
+ λ1
(
kbb(1− b)− bknrn+ δ
λrbb+ 1
w
w + kw
− λbb
)
+ λ2
(
kpe
−λpt(1− n) + knibn(1− n)(gnw(w))
λnin+ 1
− λnn
1 + eb
)
.
+ λ3 (β + γu(t)− λww − λbwbw − λnwnw)
(7)
Thus the adjoint equations (by Theorem I.1) are as follows:
λ′1 = −
∂H
∂b
= −
[
1 + λ1
(
kb − 2kbb− λb + (knrn+ δ)bλrb − (λrbb+ 1)(knrn+ δ)
(λrbb+ 1)2
w
w + kw
)
+ λ2
(
knin(1− n)(gnw(w))
λnin+ 1
+
λnne
(1 + eb)2
)
+ λ3(−λbww)
]
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λ′2 = −
∂H
∂n
= −
[
λ1(
−bknr
λrbb+ 1
w
w + kw
)
+ λ2
(
gnw(w)[(λnin+ 1)(knib− 2knibn)− knibn(1− n)λni]
(λnin+ 1)2
− λn
1 + eb
− kpe−λpt
)
+ λ3(−λnww)
]
λ′3 = −
∂H
∂w
= −
[
λ1
(−b(knrn+ δ)
λrbb+ 1
kw
(w + kw)2
)
+ λ2
(
knibn(1− n)(g′nw(w))
λnin+ 1
)
+ λ3 (−λw − λbwb− λnwn)
]
where g′nw(w) =
 6w
2 − 6w for 0 ≤ w < 1,
0 for w ≥ 1,
with the final time values:
λ1(T ) = 0, λ2(T ) = 0, λ3(T ) = 0.
Since
∂H
∂u
= cu+ γλ3, the optimality conditions are given below:
u∗(t) =

0 implies cu+ γλ3 ≥ 0 at t,
0 <
−γλ3
c
< M2 implies cu+ γλ3 = 0 at t,
M2 implies cu+ γλ3 ≤ 0 at t.
Thus the optimality system that characterizes our optimum control
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J [u(t)] =
∫ t1
0
[
b(t) +
c
2
u2(t)
]
dt is given by:

db
dt
= kbb(1− b)− b
knrn + δ
λrbb + 1
w
w + kw
− λbb
dn
dt
= kpe
−λpt(1− n) + knibn(1− n)gnw
λnin + 1
− λnn
1 + eb
dw
dt
= β + γu(t)− λww − λbwbw − λnwnw
n(0) = 0, b(0) = binit, w(0) = winit
λ′1 = −
∂H
∂b
= −[1 + λ1
(
kb − 2kbb− λb +
(knrn + δ)bλrb − (λrbb + 1)(knrn + δ)
(λrbb + 1)
2
w
w + kw
)
+λ2
(
knin(1− n)(gnw(w))
λnin + 1
+
λnne
(1 + eb)2
)
+ λ3(−λbww)]
λ′2 = −
∂H
∂n
= −[λ1(
−bknr
λrbb + 1
w
w + kw
)
+λ2
(
gnw(w)[(λnin + 1)(knib− 2knibn)− knibn(1− n)λni]
(λnin + 1)2
− λn
1 + eb
− kpe−λpt
)
+ λ3(−λnww)]
λ′3 = −
∂H
∂w
= −[λ1
(
−b(knrn + δ)
λrbb + 1
kw
(w + kw)2
)
+ λ2
(
knibn(1− n)(g′nw(w))
λnin + 1
)
+λ3 (−λw − λbwb− λnwn)]
λ1(T ) = 0, λ2(T ) = 0, λ3(T ) = 0.
Nonlinear Existence
In order to show existence of an optimal control, u∗, we will use an
adaptation of an existence result Theorem III.4.1 from Fleming and Rishel (1975).
We will need this theorem by Lukes (1982) for the existence proof later.
Theorem II.2. The Cauchy problem
dx
dt
= g(t, x(t)), x|t=τ = ξ where (τ, ξ) ∈ D,
with D a nonempty open subset of R× Rn and f : D → Rn has a solution if for
some Ra,b = {(t, x) : |t− τ | ≤ a, |x− ξ| ≤ b, a, b > 0} ⊂ D centered about (τ, ξ) the
restriction of g to Ra,b is continuous in x for fixed t, measurable in t for fixed x, and
satisfies |g(t, x)| ≤ m(t), (t, x) ∈ Ra,b for some m integrable over the interval
[τ − a, τ + a].
Existence of an optimal control is shown in Theorem II.3.
Theorem II.3. Let L be the integrand of the objective functional, ~g be the
right-hand side of the differential equations, U be a closed subset of En, the space of
n tuples x = (x1, ..., xn) of real numbers. Let F ′ be the class of all (x0, u) such that u
is a Lebesque-integrable function on the interval [t0, t1] with values in U and the
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solution of the differential equations satisfying the end conditions e ∈ S. Let S be a
given subset of E2n+2 and J(x0, u) = φj(t0, t1, x(t0), x(t1)) = φ(e) for j = 2, ..., k and
e denotes a (2n+2)-tuple of end points. For each (t, x) ∈ En+1, let
F˜ (t, x) = {z˜ : z = g(t, x, u), zn+1 ≥ L(t, x, u), u ∈ U}.
Suppose that ~g is continuous; there exist positive constants C1, C2 such that
(a) |~g(t, x, u)| ≤ C1(1 + |x|+ |u|),
(b) |~g(t, x′, u)− g(t, x, u)| ≤ C2|x′ − x|(1 + |u|) for all t ∈ E1, x, x′ ∈ En, and
u ∈ U , L is continuous,
and that:
1. F ′ is not empty;
2. U is closed;
3. S is compact and φ is continuous on S;
4. F˜ (t, x) is convex for each (t, x) ∈ En+1;
5. L(t, x, u) ≥ h(u), where h is continuous and |u|−1h(u)→ +∞ as
|u| → ∞, u ∈ U . Then there exist (x∗0, u∗) minimizing J(x0, u) on F ′.
In order to show the above we must check the following properties which are
equivalent to the general conditions stated above (Joshi, 2002):
1. The set of controls and corresponding state variables is non-empty.
2. The control U set is convex and closed.
3. The RHS of the state system is bounded by a linear function in the state and
control variables.
4. The integrand of the objective functional is convex on U .
5. There exist constants c1, c2 > 0, and β > 1 such that the integrand L(t, x, u)
satisfies
L(t, x, u) ≥ c1|u|β − c2.
We apply the above result to minimize equation (6) with respect to the state
system described by equations 1-3 with the appropriate initial conditions.
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Proof. In order to show:
1. We use a result by Lukes (Theorem 9.2.1 pg 182 (see Theorem II.2);
Differential Equations: Classical to Controlled) which gives the existence of
solutions of ODEs with bounded coefficients.
2. U , as defined in (4), is closed and convex because our differential equation is
linear in u so it is convex. U is closed because 0 ≤ u ≤M2.
3. The RHS of the state system is bounded by a linear function in the state and
control because we know that bacteria and neutrophils are bounded by the
carrying capacities b0 and n0, respectively. Note that the non-dimensional
values for b0 and n0 are one. The amount of oxygen is bounded by
max
{
winit,
β + γ ∗M2
λw
}
, where M2 is the maximum amount of oxygen input
allowed.
To show this, we know that 0 ≤ u ≤M2 and allowing α = β + γ ∗M2 we have
that
dw
dt
= α− λw ∗ w is maximized because we are inputting the maximum
amount of oxygen (u = M2) and we are not accounting for any oxygen used
by bacteria or neutrophils by letting n = b = 0. Solving the differential
equation, by separation of variables,
dw
dt
= α− λw ∗ w∫ dw
α− λw ∗ w =
∫
dt letting u = α− λw ∗ w, du = −λwdw
ln |α− λw ∗ w| = −λwt+ c
α− λw ∗ w = e−λw+c
w =
α− C ∗ e−λwt
λw
w(0) =
α− C
λw
= winit
C = α− λw ∗ winit.
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Thus we claim that
w¯(t) =
α(1− e−λwt) + λw ∗ winite−λwt
λw
bounds our oxygen function, w, above. We need to show that w¯(t) is
decreasing when winit >
α
λw
and increasing when winit <
α
λw
. If w¯(t) is
decreasing, then the maximum value is w(0) = winit. If w¯(t) is increasing then
the maximum value is lim
t→∞
w(t) =
α
λw
=
β + γ ∗M2
λw
. Where,
w¯′(t) =
dw¯(t)
dt
= (α− λw ∗ winit)e−λwt.
Thus w is bounded above by w¯ and the maximum value for the oxygen is
given by max
{
winit,
β + γ ∗M2
λw
}
. Thus,
M = max
{
b0, n0, winit,
β + γ ∗M2
λw
}
bounds the states and control variables
and provides a constant function that bounds the RHS of the state system.
4. The integrand of the objective function is convex on U because b+
c
2
u2 is a
convex function as defined in Bartle and Sherbert, Theorem 5.4.6: “Let I be
an open interval and suppose that f : I → R has a second derivative on I.
Then f is a convex function on I iff f ′′(x) ≥ 0 for all x ∈ I.” The second
derivative of b+
c
2
u2 = c > 0.
5. Let c1 = c > 0, c2 > 0 and β = 2. Thus b+ cu
2 ≥ c1|u|2 − c2.

Nonlinear Uniqueness
To show uniqueness of the optimal control solutions for the optimality system, we
use a theorem given in Joshi et al. 2006. The optimality system consists of the state
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system, adjoint system, initial conditions, transversality conditions and the
characterization of the optimal control.
Consider the boundary value problem

~x(t)′ = ~p(t, x, λ) = (b(t)′, n′(t), w′(t))ᵀ,
~λ′(t) = ~q(t, x, λ) = (λ′1(t), λ
′
2(t), λ
′
3(t))
ᵀ,
~x(0) = ~x0, ~λ(T ) = ~λT ,
where ~x ∈ Rm, ~λ ∈ Rn, and ~p : R× Rm × Rn → Rm and ~q : R× Rm × Rn → Rn are
continuous.
Theorem II.4. Assume that ~p and ~q are bounded and satisfy a Lipschitz condition
relative to ~x and ~λ with with constant C > 0. Then solutions of system above are
unique if T is sufficiently small.
Proof. Suppose our two-point boundary problem has two solutions (~x1(t), ~λ1(t))
and (~x2(t), ~λ2(t)). The Lipschitz condition on ~p and ~q imply
‖~x1(t)− ~x2(t)‖ ≤
∫ t
0
C(‖(~x1(s)− ~x2(s)‖+ ‖~λ1(s)− ~λ2(s)‖)ds. (8)
‖~λ1(t)− ~λ2(t)‖ ≤
∫ t
0
C(‖(~x1(s)− ~x2(s)‖+ ‖~λ1(s)− ~λ2(s)‖)ds. (9)
Adding (8) and (9) together yields
‖~x1(t)− ~x2(t)‖+ ‖~λ1(t)− ~λ2(t)‖ ≤
∫ t
0
C(‖(~x1(s)− ~x2(s)‖+ ‖~λ1(s)− ~λ2(s)‖)ds.
(10)
The Mean Value Theorem for Integrals can be applied to conclude that there exists
a ζ, 0 ≤ ζ ≤ T , such that
‖~x1(t)− ~x2(t)‖+ ‖~λ1(t)− ~λ2(t)‖ ≤
∫ t
0
TC(‖(~x1(ζ)− ~x2(ζ)‖+ ‖~λ1(ζ)− ~λ2(ζ)‖)ds.
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for all t ∈ [0, T ]. If T is so small that TC < 1, we arrive at a contradiction,
completing the proof. 
Introduction: Numerical Analysis
We will use a forward-backward sweep method in order to solve the optimal
control problem numerically. In our problem, we are given initial conditions for the
state equations ~x, but final conditions for the adjoint equations ~λ. We divide our
time interval [t0, t1] into N equally spaced points. There are 5 basic steps in the
forward-backward sweep method, as outlined in Lenhart and Workman.
1. Make an initial guess about ~u over the interval.
2. Using the initial condition x1 = x(t0) = a and the values for ~u, solve ~x forward
in time according to its differential equation in the optimality system.
3. Using the transversality condition λN+1 = λ(t1) = 0 and the values for ~u and
~x, solve ~λ backward in time according to its differential equation in the
optimality system.
4. Update ~u by entering the new ~x and ~λ values into the characterization of the
optimal control.
5. Check convergence. If values of the variables in this iteration and the last
iteration are close (based on our convergence criteria), output the current
values as solutions. If values are not close, return to step 2.
In order to complete the steps given above, we use a Runge-Kutta 4 routine.
Given a step size h and an ODE x′(t) = f(t, x(t)) the approximation of x(t+ h)
given x(t) is
x(t+ h) ≈ x(t) + h
6
(k1 + 2k2 + 2k3 + k4)
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where
k1 = f(t, x(t))
k2 = f(t+
h
2
, x(t) +
h
2
k1)
k3 = f(t+
h
2
, x(t) +
h
2
k2)
k4 = f(t+
h
2
, x(t) + hk3).
We also use the Runge-Kutta 4 routine to go backwards by replacing
h
2
by −h
2
.
Non-linear Bounded Test Problem
In order to solve our non-linear control numerically, we formulated a test
problem that could be solved analytically to test our coding and to help us learn
about any potential pitfalls. We wanted this problem to be like our problem
J [u(t)] =
∫ t1
0
[
b(t) +
c
2
u2(t)
]
dt. So we chose to solve a similar problem (adapted
from Lenhart and Workman Example 3.5):
min
−0.5≤u≤0.5
∫ 1
0
[x2 + u
2]du
subject to: 
x′1 = x2
x′2 = x1 + u
λ′1 = −λ2
λ′2 = −λ1 − 1
x1(0) = 0, x2(0) = 0, λ1(1) = 0, λ2(1) = 0.
Our Hamiltonian for this problem is H = x2 + u
2 + λ1x2 + λ2(x1 + u). Our
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partial derivative of H with respect to u is
∂H
∂u
= 2u+ λ2. Thus we have,

∂H
∂u
> 0⇒ u > −λ2
2
implies u∗ = −0.5⇒ λ2 > 1
∂H
∂u
= 0⇒ u = −λ2
2
implies − 0.5 ≤ u∗ ≤ 0.5⇒ −1 ≤ λ2 ≤ 1
∂H
∂u
< 0⇒ u < −λ2
2
implies u∗ = 0.5⇒ λ2 < −1.
(11)
Notice that λ′′1 = −λ′2 so λ′′1 = λ1 + 1 and λ1(1) = 0, λ′1(1) = 0. Let y = λ1 + 1 then
y′′ = y with y(1) = 1, y′(1) = 0. So we have
y(t) = c1 ∗ et + c2 ∗ e−t
y′(1) = c1 ∗ e− c2 ∗ e−1 = 0
⇒ c2 = c1 ∗ e2.
Then,
y(t) = c1(e
t + e2−t)
y(1) = c1(e+ e) = 1⇒ c1 = .5e−1
y(t) =
1
2
(et−1 + e1−t)
λ1(t) =
1
2
(et−1 + e1−t)− 1
−λ2(t) = λ′1(t) =
1
2
(et−1 − e1−t)
λ2(t) = −1
2
(et−1 + e1−t) = − sinh(t− 1).
We want to see what time makes λ2 > 1 in (11), so we have u
∗ in terms of t because
when u∗ = −0.5 then λ2 > 1:
λ2(t) = − sinh (t− 1) > 1
sinh (t− 1) < −1
t < 1 + sinh−1 (−1) = 1 + ln (−1 +√2) ≈ 0.1186.
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Likewise, want to see at what time λ2 < −1:
λ2(t) = − sinh (t− 1) < −1
λ2(t) = sinh (t− 1) > 1
t− 1 > sinh−1 (1)
t > 1 + sinh−1 (1) = 1 + ln(1 +
√
2) ≈ 1.8814.
The optimal control is:
u∗ =

−0.5 when t < 0.1186
1
2
sinh (t− 1) when 0.1186 ≤ t ≤ 1.8814
0.5 when t > 1.8814.
This solution is continuous. In order to find x∗1(t) and x
∗
2(t), we will substitute in
our values for the optimal control, u∗ and solve. We will only be considering two
cases because our optimal state is continuous and 0 ≤ t ≤ 1, specifically t < 0.1186
and t ≥ 0.1186. We can apply the boundary conditions x1(0) = 0, x2(0) = 0. As
shown previously, u∗ during this time frame is -0.5. We must then solve:

x′1 = x2
x′2 = x1 − 0.5
x1(0) = 0, x2(0) = 0.
Similar to what we did with λ1 above, we have x
′′
1 = x1 − 0.5 and x′1(0) = 0. Let
y = x1 − 0.5. Then y′′ = y, y(0) = −0.5, y′(0) = 0. Solving yields
y(t) = d1 ∗ et + d2 ∗ e−t
y′(0) = d1 − d2 = 0→ d1 = d2
y(0) = d1 + d2 = 2d1 = −0.5
y(t) = −0.5 ∗ e
t + e−t
2
= −0.5 ∗ cosh (t).
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Thus, x1(t) = −0.5 cosh(t) + 0.5 and x2(t) = −0.5 sinh(t). For 0.1186 ≤ t ≤ 1
we can no longer use our initial conditions because t 6= 0. Since our state equations
must be continuous, we can solve for our coefficients by setting our solution for case
two equal to that of case one at t = sinh−1 (−1) + 1. In case two our goal is to solve:
 x
′
1 = x2
x′2 = x1 + 0.5 ∗ sinh (t).
We solved case two using Mathematica and concluded:

x1 =
1
8
+
√
2t
4
+
1
8
∗ (−4 + e(−3
2
+
√
2 + sinh−1 (1)) +
−1
2
+
√
2 + sinh−1 (1)
e
) ∗ cosh (t)
+
1
16 ∗ e ∗ (−1 + 2 ∗
√
2 + e2 ∗ (3− 2√2− 2 sinh−1 (1)) + 2 sinh−1 (1)) ∗ sinh (t)
x2 =
√
2
8
− t
4
1
8
∗ (−4 + e(−3
2
+
√
2 + sinh−1 (1)) +
−1
2
+
√
2 + sinh−1 (1)
e
) ∗ sinh (t)
+
1
16 ∗ e ∗ (−1 + 2 ∗
√
2 + e2 ∗ (3− 2√2− 2 sinh−1 (1)) + 2 sinh−1 (1)) ∗ cosh (t).
Putting case one and two together gives us our optimal state equations.
x
∗
1

for 0 ≤ t < sinh−1 (−1) + 1 :
0.5− 0.5 ∗ cosh (t)
for sinh−1 (−1) + 1 ≤ t ≤ 1 :
1
8
+
√
2t
4
+
1
8
∗ (−4 + e(−3
2
+
√
2 + sinh−1 (1)) +
−1
2
+
√
2 + sinh−1 (1)
e
) ∗ cosh (t)
+
1
16 ∗ e ∗ (−1 + 2 ∗
√
2 + e2 ∗ (3− 2√2− 2 sinh−1 (1)) + 2 sinh−1 (1)) ∗ sinh (t)
x
∗
2

for 0 ≤ t < sinh−1 (−1) + 1
−0.5 ∗ sinh (t)
for sinh−1 (−1) + 1 ≤ t ≤ 1
√
2
8
− t
4
1
8
∗ (−4 + e(−3
2
+
√
2 + sinh−1 (1)) +
−1
2
+
√
2 + sinh−1 (1)
e
) ∗ sinh (t)
+
1
16 ∗ e ∗ (−1 + 2 ∗
√
2 + e2 ∗ (3− 2√2− 2 sinh−1 (1)) + 2 sinh−1 (1)) ∗ cosh (t)
We let our convergence tolerance be selected as ζ = 0.001. We require the
relative error to be small and ζ chosen to satisfy
|u− oldu|
|u| ≤ ζ. In order to allow
for zero controls, we cannot divide by zero. This is equivalent to
ζ|u| − |u− oldu| ≥ 0, or ζΣN+1i=1 |ui| − ΣN+1i=1 |ui − oldui| ≥ 0.
After we performed the forward-backward sweep method, we needed to solve
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for u using our updated value. Let u1 = max( 0, min(u value when
∂H
∂u
= 0, M2)),
where 0 is the lower bound of u and M2 is the upper bound of u. We average this
value with our previous value to determine the updated value of u. We then test for
convergence of our u, x1, x2, λ1, and λ2 to determine if the program needs to run
again (there is still a negative term) or has finished (each term is non-negative) and
the program can exit the while loop. Figures (1) and (2) show that our numerical
and analytical solutions match for the state, adjoint, and control variables.
Figure 1: This figure shows that our values for ~x and ~λ from our analytical and
numerical solutions match, because the two solutions overlap.
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Figure 2: The figure above shows that our values for u, our control from our analytical
and numerical solutions match, because the two solutions overlap.
Non-linear Solution
Using the Hamiltonian given by (7) and the numerical method given in the
introduction to numerical analysis, along with testing our numerical methods by
comparing different initial conditions and parameters in order to meet our
convergence criteria, we have been able to find several biologically reasonable
solutions to this problem.
First we tried to follow the numerical method used in our test problems.
Using this method our value for u, input of oxygen, is updated by a simple average
u = 0.5 ∗ (u1 + oldu) where u1 is the current iterative value of u and oldu is the
previous iteration’s value for u. We modified the parameter values of knr, δ, λbw and
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λnw, because they work to kill the bacteria faster, in order to increase the likelihood
of convergence. The parameter values used are shown in Figure 3. The A,B,C,D
indicate what number was multiplied or divided from knr, δ, λbw and λnw,
respectively. We chose A B since the bulk of the oxidative killing is due to the
presence of the neutrophils. To keep the same ratio for
λbw
λnw
, we chose C = D.
Unless otherwise given A,B,C,D = 80, 8, 3, 3 respectively. These parameters are
from the work of Schugart and Joyce. Figure 4 illustrates the numerical solution for
the parameter values given in Figure 3. Note that for these parameter values,
bacteria persist in the wound.
Figure 3: These are the parameter values used in our codes. Unless otherwise speci-
fied, A,B,C,D = 80, 8, 3, 3, respectively.
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Figure 4: These are the results when no oxygen is given. Note that the bacteria
persist in the wound.
However, we were unable to find cases that numerically converged and the
bacteria persisted with no input of oxygen, but died with oxygen input. We varied
initial guesses for bacteria, neutrophils, and oxygen. We also considered different
initial conditions for our control, specifically: 0.5, 0, and -M2*t/tf+M2 (see Figure
5). The last is the line from maximum allowed oxygen input (M2=16.37) to
minimum oxygen input, 0. Yet, even with these changes, the code failed to converge
(see Table 1, where DNC means Does Not Converge) as we let the code run for
25,000 iterations.
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Figure 5: These are the initial guess values for u. They are entered as a vector and
then adjusted with as each iteration of the code runs.
Table 1: These are the results for when u is updated by averaging the previous
iteration value of u with its current iteration value.
Since the code failed to converge, we tried changing how we updated u in our
code. We used a convex combination of the old u and new u (Figure 6), as
suggested in Lenhart and Workman (2007).
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Figure 6: This code compares our old and new u and then creates a weighted average
based on the number of iterations run.
While our numerical simulations met convergence criteria, our results with
this method varied greatly with different initial guesses for u. This potentially
suggests that there may be some numerical instability in the code. When we started
with a zero value for u, the bacteria in the wound persisted, which is indicated by P,
in Table 2 on page 30. When we started with u = 0.5 we had mixed results of
bacteria sometimes persisting and sometimes being removed from the wound. The
bacteria persisted whenever the parameters were A,B,C,D = 100, 5, 2, 2,
respectively. However, our J values (the sum over all our time steps of the objective
functional) were relatively large suggesting a better numerical method can improve
our results. Observe these J values in Table 2. The lowest J value is 624.2647 and
15/27 of the results are greater than 10,000. When we used u = −M2 ∗ t/tf +M2
we obtained convergence in all the cases tested, but again our J values were very
large, around 1.34 ∗ 104. Figures (7 - 9) and Table (2) illustrate varying these three
inputs of u for this case.
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Figure 7: Results for u initially 0 and (b, n, w) = (0.9, 0.2, 0.5). The bacteria and
neutrophils persist in the wound for the 14 day period. Oxygen is not administered
until right before the end of the 14 days.
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Figure 8: Results for u initially 0.5 and (b, n, w) = (0.9, 0.2, 0.5). Here the bacteria is
removed quickly from the wound in approximately 1/4 of a day. The oxygen input
remains at the dimensionless maximum of 16.37 for the whole time. Neutrophils leave
the wound and the oxygen in the wound (w) rises again because it is not being used
by the bacteria or neutrophils. This is not a biologically reasonable solution though
because this much oxygen for this length of time would cause oxygen toxicity.
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Figure 9: Results for u initially -M2 ∗ t/tf +M2 and (b, n, w) = (0.9, 0.2, 0.5). Here
the bacteria is removed quickly from the wound in approx 1/4 day. The oxygen input
remains at the dimensionless maximum of 16.37 for the whole time. Neutrophils leave
the wound and the oxygen in the wound (w) rises again because it is not being used
by the bacteria or neutrophils. This is not a biologically applicable solution though
because this much oxygen for this length of time would cause oxygen toxicity.
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Figure 10: Results for u initially 0.5 and (b, n, w) = (0.9, 0.2, 0.5) changing parameters
slightly yields a different shape of u results. Here A,B,C,D = 80, 8, 4, 4 respectively.
The bacteria is removed from the wound in approximately 1.75 days. Oxygen input
is withheld until slightly before 1.75 days and then is given at the dimensionless
maximum amount 16.37. Again, this is not a biologically applicable solution though
because this much oxygen for this length of time would cause oxygen toxicity.
Table 2: These are the results for when u is updated by weighting the average of the
previous iteration value of u with its current iteration value.
Notice that when a initial value of zero is given for our input of oxygen the
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bacteria persists but in our other two cases the bacteria levels go to zero and the
oxygen input levels remain at the maximum the whole time. These results show
dependence on the initial guess of u, which implies instability of the method so we
wanted to try to find a numerical scheme that is less likely to be dependent on an
initial guess of u.
We decided to try the steepest descent algorithm because the initial guess we
use is not crucial for convergence (Kirk, 2004). The steepest descent algorithm
works to minimize
∂H
∂u
(where a minus indicates going in the direction of a
minimum). The change in position (
4u
4t ) is proportional to the vector in the
gradient direction toward minimum point (−∂H
∂u
) so,
4u
4t = −
∂H
∂u
We want to minimize
∂H
∂u
.
ui+1 − ui = 4u = −4t∂H
∂u
Solving for ui+1 yields
ui+1 = ui −4t∂H
∂u
.
Therefore the code updates u by making our new u equal to our old u minus our
step size times the partial of the Hamiltonian with respect to u, where 4t is the
step size. How we apply this to our u is shown in Figure 11. Note that we still
ensure that our values for u are between 0 and M2.
Figure 11: Updating u using steepest descent algorithm.
Our convergence criteria also changes with this algorithm. Now we are
testing to see that
∥∥∥∥∂H∂u
∥∥∥∥ ≤ ζ. We decided to let ζ = 1. Solutions did not differ
greatly for smaller values of ζ, such as 0.1, which is why we chose ζ = 1. Figures
(12-14) show the similarities between our three initial guesses for u = 0, 0.5, and
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-M2*t/tf+M2.
Figure 12: Here we see that our bacteria dies in a little under a day. Our oxygen input
also goes back to zero shortly after this occurs. This is more biologically applicable
solution than our previous results but we cannot administer hyperbaric oxygen for a
day because of the risk of oxygen toxicity.
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Figure 13: Here we see that our bacteria dies in a little under a day. Our oxygen input
also goes back to zero shortly after this occurs. This is more biologically applicable
solution than our previous results but we cannot administer hyperbaric oxygen for a
day because of the risk of oxygen toxicity.
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Figure 14: Here we see that our bacteria dies in a little under a day. Our oxygen input
also goes back to zero shortly after this occurs. This is more biologically applicable
solution than our previous results but we cannot administer hyperbaric oxygen for a
day because of the risk of oxygen toxicity.
Figures 12-14 all show the bacteria being removed from the wound in under
a day as well as the input of oxygen being reduced to zero in under a day. The
similarity within these results given different initial guesses for u, shows the stability
of the steepest descent algorithm as compared to the weighted average method. We
also see a more biologically applicable solution as the bacteria leave the wound
within a day. Table 3 summarizes our results after using the steepest descent
algorithm. Notice that the J values are consistent as different initial conditions for
u and parameter values are given, especially when the parameter values are 70,6,5,5.
The smallest J value is approximately 25 and the largest is approximately 75, which
has a difference of 50. Compare this to Table 2 where the smallest was
approximately 800 and the largest 13,400, which has a difference of 12,600. This
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also indicates that the steepest descent code is stable.
Table 3: These are the results for when u is updated by the steepest descent algorithm.
Our oxygen input increased in the beginning until our bacteria died. Then
our input of oxygen went back to zero. This follows the behavior we would expect
to see biologically.
There are also a couple different functionals that we might want to consider.
We have already looked at what happens if we let c, our weighting coefficient of u in
the objective functional, be negative. This models minimizing bacteria while
maximizing oxygen over small time. Since the control is bounded, it is not
unreasonable to consider what happens when we maximize the oxygen therapy. The
goal is to find an optimal solution that removes the bacteria from the wound.
Letting c = −0.1 instead of c = 0.1 yields results that do not converge within 25,000
iterations. We also considered what would happen if we minimized
∫ t1
0
[
b2 +
cu2
2
]
dt
as well as
∫ t1
0
[
b3 +
cu2
2
]
dt and concluded that for b close to one this case is not
much different than the case already considered. We then considered what would
happen if
dw
dt
was changed to be
dw
dt
= β + γ ∗ uα(t)− λww− λbwbw− λnwnw, where
our oxygen input is raised to α, a power greater than 2. This was determined to
have a u ≡ 0 as the minimal solution because when we take ∂H
∂u
we can always
factor out u.
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III. LINEAR CONTROL
Forming the Hamiltonian for Linear Control
In this section, we form the Hamiltonian for our linear control
J(u(t)) =
∫ T
0
[b(t) + cu(t)] dt,
where 0 ≤ u ≤M2.
(12)
This will model supplemental oxygen administered in the wound through topical
oxygen therapy. A linear function is reasonable because the oxygen is being
delivered to the wound directly. We will continue to use the differential equations
provided above from Schugart and Joyce.
Linear Existence
We will prove existence using a theorem from the work of Filippov-Cesari from
‘Optimal Control Theory With Economic Applications’ by Seierstad and Sydsaeter
(1987, p. 285 Theorem 2). Consider the following problem,
max
∫ t1
t0
f0(x(t), u(t))dt, (t0, t1 fixed)
subject to the vector differential equation and the initial condition
d~x
dt
= f(~x(t), u(t), t), x(t0) = x
0(x0 fixed),
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the terminal conditions
xi(t1) = x
1
i i = 1, ..., l (x
1
i all fixed)
xi(t1) ≥ x1i i = l + 1, ...,m (x1i all fixed)
xi(t1) free i = m+ 1, ..., n,
and for all t ∈ [t0, t1], the constraints
hk(x(t), u(t), t) ≥ 0, k = 1, 2, ..., s.
If:
1. There exists an admissible pair (x(t), u(t)).
2. The set N(x, t) = {f0(x, u, t) + ρ, f(x, u, t)) : ρ ≤ 0, h(x, u, t) ≥ 0} is convex for
all x and all t ∈ [t0, t1].
3. There exists a number b such that ||x(t)|| ≤ b for all admissible pairs
(x(t), u(t)), and all t ∈ [t0, t1].
4. There exists a ball B(0, b1) in R
r which, for all x with
U(x, t) = {u : h(x, u, t) ≥ 0}.
Then there exists an optimal (measurable) control.
Proof.
1. (x(t), u(t)) is an admissible pair because u(t) is piecewise continuous, x(t) is
continuous and piecewise continuously differentiable, and it satisfies the vector
differential equation, initial conditions, constraints, with free terminal
conditions.
2. The set N(x, t) = {f0(x, u, t) + ρ, f(x, u, t)) : ρ ≤ 0, h(x, u, t) ≥ 0} is convex for
all ~x and all t ∈ [t0, t1] by the definition given in Lenhart and Workman of
convex, “A function k(t) is said to be convex on [a,b] if
αk(t1) + (1− α)k(t2) ≤ k(αt1 + (1− α)t2) for all 0 ≤ α ≤ 1 and for any
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a ≤ t1, t2 ≤ b.” For our problem, we have:
f0 = b+ cu
f0(~x, u1) + ρ = b+ cu1 + ρ
f0(~x, u2) + ρ = b+ cu2 + ρ
f0(~x, u2)− f0(~x, u1) = c(u2 − u1)
∂f0(~x, u)
∂u
= c
⇒ (u2 − u1)∂f0(~x, u2)
∂u
= c(u2 − u1),
and
f = β + γu− λww − λbwbw − λnwnw
f(~x, u1) = β + γu1 − λww − λbwbw − λnwnw
f(~x, u2) = β + γu2 − λww − λbwbw − λnwnw
f(~x, u2)− f(~x, u1) = γ(u2 − u1)∂f(~x, u2)
∂u
= γ
⇒ (u2 − u1)∂f(~x, u2)
∂u
= γ(u2 − u1).
Furthermore, if k is differentiable, then k is convex if and only if
k(t2)− k(t1) ≤ (t2 − t1)k′(t2). This property holds trivially in our case because
ct2 − ct1 ≤ (t2 − t1)c.
3. There exists a number b such that ||x(t)|| ≤ b for all admissible pairs
(x(t), u(t)), and all t ∈ [t0, t1]. b = max
{
b0, n0, winit,
β + γ ∗M2
λw
}
as shown
in the section on nonlinear existence.
4. There exists a ball B(0, b1) in R
r which, for all x with
U(x, t) = {u : h(x, u, t) ≥ 0} which is a convex subset of Rr, where r is the
number of control variables. This is true because u is always between [0,M ],
||x(t)|| ≤ b, and t ∈ [0, t1], t1 is final time, so U(x, t) = {u : h(x, u, t) ≥ 0}.
Royden 1988 defines convexity by saying, A subset k of a vector space X is
convex if whenever it contains x, y it also contains λx+ (1− λ)y for 0 ≤ λ ≤ 1.
Let x, y ∈ U . Assume without loss of generality 0 ≤ x ≤ y ≤M . Let
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h1(u) = u ≥ 0, h2 = M − u ≥ 0. Then
h1(x) ≥ 0⇒ x ≥ 0,
h1(y) ≥ 0⇒ y ≥ 0,
h2(x) ≥ 0⇒ M − x ≥ 0,
h2(y) ≥ 0⇒ M − y ≥ 0.
Let w = λx+ (1− λ)y ∈ U for 0 ≤ λ ≤ 1. We need to show that h1(w) ≥ 0
and h2(w) ≥ 0.
h1(w) = λx+ (1− λ)y ≥ 0
h2(w) = M − λx− (1− λ)y
= M − y + λy − λx
= M − y + λ(y − x) ≥ 0 for x ≤ y.
Thus, U is convex.
Thus, there exists an optimal (measurable) control for our linear case. 
The Hamiltonian for the linear control without bounds is:
H = b+ cu
+ λ1
(
kbb(1− b)− bknrn+ δ
λrbb+ 1
∗ w
w + kw
− λb ∗ b
)
+ λ2
(
kpe
−λpt(1− n) + knibn(1− n)(gnw(w))
λnin+ 1
− λnn
1 + eb
)
+ λ3 (β + γ ∗ u(t)− λww − λbwbw − λnwnw) .
(13)
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Thus the adjoint equations (from Theorem I.1) are as follows:
λ′1 = −
∂H
∂b
= −
[
1 + λ1
(
kb − 2kbb− λb + (knrn+ δ)bλrb − (λrbb+ 1)(knrn+ δ)
(λrbb+ 1)2
∗ w
w + kw
)
+ λ2
(
knin(1− n)(gnw(w))
λnin+ 1
+
λnne
(1 + eb)2
)
+ λ3(−λbww)
]
,
λ′2 = −
∂H
∂n
= −
[
λ1
( −bknr
λrbb+ 1
w
w + kw
)
+ λ2
(
gnw(w)[(λnin+ 1)(knib− 2knibn)− knibn(1− n)λni]
(λnin+ 1)2
− λn
1 + eb
− kpe−λpt
)
+ λ3(−λnww)
]
,
λ′3 = −
∂H
∂w
= −
[
λ1
(−b(knrn+ δ)
λrbb+ 1
∗ kw
(w + kw)2
)
+ λ2
(
knibn(1− n)(g′nw(w))
λnin+ 1
)
+ λ3 (−λw − λbwb− λnwn)
]
,
where g′nw(w) =
 6w
2 − 6w for 0 ≤ w < 1,
0 for w ≥ 1.
With the final time values:
λ1(T ) = 0, λ2(T ) = 0, λ3(T ) = 0.
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Thus the optimality system that characterizes our optimum control (12) is given by:

db
dt
= kbb(1− b)− b
knrn + δ
λrbb + 1
∗ w
w + kw
− λbb
dn
dt
= kpe
−λpt(1− n) + knibn(1− n)gnw
λnin + 1
− λnn
1 + eb
dw
dt
= β + γ ∗ u(t)− λww − λbwbw − λnwnw
n(0) = 0, b(0) = binit, w(0) = winit
λ′1 = −
∂H
∂b
= −[1 + λ1
(
kb − 2kbb− λb +
(knrn + δ)bλrb − (λrb ∗ b + 1)(knrn + δ)
(λrbb + 1)
2
∗ w
w + kw
)
+λ2
(
knin(1− n)(gnw(w))
λni ∗ n + 1
+
λn ∗ ne
(1 + eb)2
)
+ λ3(−λbww)]
λ′2 = −
∂H
∂n
= −[λ1 ∗ (
−bknr
λrbb + 1
∗ w
w + kw
)
+λ2
(
gnw(w)[(λni ∗ n + 1)(knib− 2knibn)− knibn(1− n)λni]
(λnin + 1)2
− λn
1 + eb
− kpe−λpt
)
+ λ3(−λnww)]
λ′3 = −
∂H
∂w
= −[λ1
(
−b(knrn + δ)
λrbb + 1
∗ kw
(w + kw)2
)
+ λ2
(
knibn(1− n)(g′nw(w))
λnin + 1
)
+ λ3 (−λw − λbwb− λnwn)]
λ1(T ) = 0, λ2(T ) = 0, λ3(T ) = 0.
Numerical Analysis
Solving a linear control is more difficult than solving for a non-linear control
because the optimal solution may be piecewise continuous in u∗, as opposed to
continuous.
Following the work of Lenhart and Workman, consider the optimal control
problem
min
u
∫ 14
0
b+ cu(t)dt
subject to
db
dt
= kbb(1− b)− bknrn+ δ
λrbb+ 1
∗ w
w + kw
− λbb,
dn
dt
= kpe
−λpt(1− n) + knibn(1− n)gnw
λnin+ 1
− λnn
1 + eb
,
dw
dt
= β + γ ∗ u(t)− λww − λbwbw − λnwnw,
n(0) = 0, b(0) = binit, w(0) = winit,
0 ≤ u(t) ≤ 5,
where gnw(w) =
 2w
3 − 3w2 + 2 for 0 ≤ w < 1,
1 for w ≥ 1.
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Notice the integrand function b+ cu(t) and the right-hand side of the
differential equations
db
dt
,
dn
dt
,
dw
dt
are both linear functions of the variable u. Thus,
the Hamiltonian is also a linear function of u, and can be written
H = b+ cu
+ λ1
(
kbb(1− b)− bknrn+ δ
λrbb+ 1
∗ w
w + kw
− λb ∗ b
)
+ λ2
(
kpe
−λpt(1− n) + knibn(1− n)(gnw(w))
λnin+ 1
− λnn
1 + eb
)
+ λ3 (β + γ ∗ u(t)− λww − λbwbw − λnwnw)
.
The necessary condition λ′ = −∂H
∂~x
(see the linear Hamiltonian section for these
conditions) is as normal. However, the optimality condition
∂H
∂u
= c+ γλ3,
contains no information on the control. We must try to minimize the Hamiltonian
H with respect to u using the sign of
∂H
∂u
, but when c+ γλ3 = 0, we cannot
immediately find a characterization of u∗.
Define ψ(t) = c+ γλ3, usually called the switching function. If ψ = 0 cannot
be sustained over an interval of time, but occurs only at finitely many points, then
the control u∗ is referred to as bang-bang because it can jump from its maximum to
minimum value or vice-versa. In this case, it is a piecewise constant function,
switching between only the upper and lower bounds.
u∗ is called singular if ψ ≡ 0 over some interval of time. In order to
determine a characterization of u∗ over the interval where ψ ≡ 0, we set ψ ≡ 0 and
see if we can solve for any other variable (usually λ) and then use substitution to
determine the value of u∗(t). Care must be taken at this point because if the value
of u∗(t) is outside of our boundary conditions for u, then the singular control is not
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achievable which forces our problem to be bang-bang.
For the linear control in our problem our characterization is given by:
u∗(t) =

0 if ψ(t) > 0
λww + λbwbw + λnwnw − β + dw
dt
γ
if ψ(t) = 0
M2 if ψ(t) < 0.
(14)
We determined u∗ by solving for u in our
dw
dt
equation (3) in the
introduction to the mathematical model. Our lower bound of oxygen input is 0 and
M2 is chosen to be 5 because Schugart and Joyce use 5 as a maximum input of
oxygen for topical therapies. The maximum amount of oxygen is lower using topical
oxygen therapy than hyperbaric oxygen therapy.
If the problem is bang-bang, we use the same forward-backward sweep that
we used for the non-linear case until we determine the control. Now instead of the
control being determined by max(0, min(u solved for when
∂H
∂u
= 0, M2)); we must
consider ψ. Now u is determined by ψ as given in (14). For the singular case, we
could put u∗ as our solution when ψ(t) = 0 but because our method is an
approximation it is unlikely that ψ will ever be exactly zero. We could try to fix
this by using the singular value for u∗ when ψ is around zero (-0.00001,0.00001) but
singular problems are often unstable for general control methods because the
switching function is identically zero on some interval.
Researchers have determined additional necessary conditions, beyond
Pontryagin’s Maximum Principle, which singular optimal controls must satisfy
(Lenhart and Workman 2007). These include a generalized Legendre-Clebsch
condition (also called a second order condition), which use higher derivatives with
respect to the states and time, not just the controls. Also numerical solvers have
been developed for problems which are linear in the control including gradient
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methods, continuation methods, iterative dynamic programming, modified
quasi-linearization methods, function space quasi-Newton methods, and adaptive
shooting methods.
Bang-Bang Test Problem
In order to solve our linear control numerically, we formulated a simpler
problem that could be solved analytically to test our coding. We wanted this
problem to be similar to J [u(t)] =
∫ t1
0
[b(t) + cu(t)] dt, so we chose to solve a similar
problem (from Lenhart and Workman Problem 17.7)
min
a≤u≤b
∫ 5
0
[4u(t) + x1(t)]dt, a < b
subject to: 
x′1 = u(t)− x2(t)
x′2 = u(t)
x1(0) = x10, x2(0) = x20.
Our Hamiltonian for this problem is H = 4u+ x1 + λ1(u− x2) + λ2u. Our
partial derivative of H with respect to u is
∂H
∂u
= 4 + λ1 + λ2 so we define our
switching function ψ to be ψ = 4 + λ1 + λ2.
Thus we can solve for λ′1 and λ
′
2 using the definitions that λ1 = −
∂H
∂x1
= 1
and λ2 = −∂H
∂x2
= −λ1. Using λ1(5) = λ2(5) = 0 we see that λ1(t) = t− 5 and
λ2(t) = −t
2
2
+ 5t− 25
2
.
If ψ = 0 on some interval then ψ = 4 + λ1 + λ2 = 0 which occurs when t = 3
and 9, but 9 is outside of our 0 ≤ t ≤ 5 time frame. So u∗ is bang-bang. Assuming u
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is a constant, k then:
 x
′
1 = k − x2 = k − kt− x20 → x1 =
−kt2
2
+ kt− x20t+ c1 = −kt
2
2
+ (k − x20)t+ x10
x′2 = k → x2 = kt+ c2 = kt+ x20
ψ = 0 implies that either k = a→ x2 = at+ x20 and k = b→ x2 = bt+ x20
at t = 3 this implies a = b which gives a contradiction to the assumption that a < b
therefore ψ 6= 0 and u cannot be singular. So we have the following:
x1(t) =
1
2
+ c1 ∗ cosh(t) + c2 ∗ sinh(t)
x1(0) =
1
2
+ c1 = 0→ c1 = −1
2
x1(t) =
1
2
+
−1
2
∗ cosh(t) + c2 ∗ sinh(t)
x2(t) = −1
2
∗ sinh(t) + c2 ∗ cosh(t)
x2(0) = c2 = 0.
Using the above and the fact that x1 is continuous at t = 3 we solve and find
that after assigning values to the variables a = 0, b = 1, x1(0) = x2(0) = 0 we have:
x1(t) =
 −
t2
2
+ t when t ≤ 3
−3t+ 15
2
when t ≥ 3,
x2(t) =
 t when t ≤ 33 when t ≥ 3.
Figures 15 and 16 show that our analytical and numerical solutions match. Another
linear test problem is given in Appendix B, which gave a bang-bang solution that is
constant, not piecewise constant.
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Figure 15: This figure shows that our values for ~x and ~λ from our analytical and
numerical solutions match, because the two solutions overlap.
Figure 16: This figure shows that our values for u from our analytical and numerical
solutions match, because the two solutions overlap. You can also see the bang-bang
of this case at t=3.
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Linear Solution
Using the Hamiltonian given in the first section and numerical analysis
methods given in the section on linear numerical analysis, we have worked to find a
linear solution.
We first tried to follow the method used in our test problem. Using this
method our value for u is updated by an average as in our non-linear solution. We
were unable to meet our convergence criteria for our linear case even after we
adjusted parameter values and tried using three different initial guesses for u (0, 0.5,
-M2*t/tf+M2), where M2=5 as we had in our non-linear case.
In Figure (17) the code has been adjusted using the convex combination or
weighted average update of u. Figure (18) shows that the bacteria persists when our
initial guess for oxygen is zero. Oxygen is administered at the dimensionless
maximum value (5) only right before the end of our 14 day time period. When we
start with oxygen being 0.5 (dimensionless value), our oxygen is administered at the
dimensionless maximum value (5) on day one, the bacteria is removed in
approximately a day but the oxygen input remains at a maximum. When the initial
input of oxygen is u =-M2*t/tf+M2, oxygen is input at a maximum value for our 14
day time period even though the bacteria is removed in under a day. These results
indicate instability with our code because the initial value for u varies our results
greatly. These results also are not useful biologically because topical oxygen cannot
be given at the maximum value for such an extended period of time.
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Figure 17: Code for linear weighted average update of u.
Figure 18: Results for u initially 0 and (b, n, w) = (0.9, 0.2, 0.5). The bacteria persist
in the wound. Oxygen is administered at the dimensionless maximum value, 5, only
right before the end of our 14 day time period.
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Figure 19: Results for u initially 0.5 and (b, n, w) = (0.9, 0.2, 0.5). Oxygen is adminis-
tered at the dimensionless maximum value, 5, at approximately a day into the model.
The bacteria is removed at that point but the oxygen remains at the maximum value.
This is not a biologically applicable solution because we want to minimize the amount
of oxygen given.
49
Figure 20: Results for u initially -M2*t/tf+M2 and (b, n, w) = (0.9, 0.2, 0.5). Oxygen
is administered at the dimensionless maximum value (5) at approximately a day into
the model. The bacteria is removed at that point but the oxygen remains at the
maximum value. This is not a biologically applicable solution because we want to
minimize the amount of oxygen given and we cannot give topical oxygen therapy for
14 days continuously.
Table 4: Results for weighted average of u in linear case.
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We are still seeking a better way to update u in order to have convergence
and less dependence on the initial guess of u. Table 4 shows the instability of this
code. All J values for u initially -M2*t/tf+M2 are over 1,000 but they are as low as
625 for u initially zero. Within each set of J values for given initial and parameter
values there are no cases where all three J values agree.
Using an interval for when ψ is close to zero (-0.00001,0.00001), as mentioned
in the linear numerical analysis section, does not change our results. We cannot use
the method of steepest descent because our
∂H
∂u
is not dependent on u in the linear
case. Thus we cannot directly control u in order to minimize
∂H
∂u
so this method is
not applicable to our linear problem.
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IV. CONCLUSIONS AND FUTURE WORK
We have developed a non-linear and linear model using optimal control
theory to represent hyperbaric and topical oxygen therapies. We provided existence
and uniqueness proofs for our non-linear case and existence for our linear case. We
then formulated test problems to compare our numerical methods to analytical
solutions before applying it to our model. Our numerical method was modified by
testing parameters, adjusting initial guesses for u, adjusting how u was updated
with each iteration of the code and modifying our convergence criteria. We also
considered various objective functionals to solve our problem.
Our results for hyperbaric oxygen treatment suggest that it is best to start
administering a large amount of oxygen and then progressively decrease to zero. For
most cases, our current results yield a person receiving oxygen for approximately a
day. However, that is above the amount of oxygen permitted to be administered
because of the risk of oxygen toxicity. We obtain similar results for different initial
conditions and parameter values.
For topical treatment, our current results are to wait a period of time and
then administer oxygen at the highest amount possible for the duration of the time
alloted in the 14 day window given. This is not an ideal result as we want to
minimize oxygen intake and this keeps oxygen at the maximum even after the wound
is healed. However, oxygen toxicity is not a problem with topical oxygen therapy.
While our convergence criteria has been met for our numerical methods, our results
indicate numerical instability and further numerical studies are warranted.
There are several areas of future work for this project. First, a more stable
method should be found for our linear case. The steepest descent algorithm does
not apply to bang-bang cases. The problem with our numerics is that we are trying
to use a gradient-based method where u is neither continuous or differentiable.
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Thus, more work should be done to approximate our function with a continuous
smooth function that can be solved numerically. From that hopefully a more
biologically applicable solution will be found.
We have not yet considered looking at minimizing J [u] =
∫
(b− cub+ du
2
2
)dt,
where c and d are constants. This would minimize bacteria, while maximizing the
input of oxygen’s effect on the bacteria and minimizing the non-linear uptake of
oxygen. Another set of functionals to consider are time-dependent functionals. In
these, we want to not only minimize the amount of oxygen input into the wound
but also the duration, in weeks, of treatments. One could begin looking at
minimizing J [u, T ] =
∫ T
0
(
1 + b+
c
2
u2
)
dt because the basic problem to minimize
time is to minimize J [u, T ] =
∫ T
0
1dt = T . Existence and uniqueness would hold by
the work shown in the sections on non-linear existence and uniqueness. Note when
minimizing final time we have new additional necessary conditions. The
Hamiltonian must be zero at the final time if there is no payoff or salvage term. See
Lenhart and Workman (Chapters 3, 20, 21) for further details. The numerics for
this kind of time dependent problem would be more difficult because we would need
to iterate the code for the final time. Newton’s method may also be able to be
applied in this situation as well.
After minimizing the duration of treatments over weeks, one could consider
minimizing the amount of treatment per day. This would help us get to a case that
is optimal and applicable to patients. Our current results are not able to be directly
applied because as they are they would cause oxygen toxicity. Another approach to
consider is trying to minimize bacteria at the final time. This would change our
terminal condition that λ(T ) = 0. Finally, we would want to consider larger-scale
models (including more equations and parameters) and partial-differential-equation
(PDE) models. However, Pontryagin’s minimum principle cannot be applied to
some PDE models (Lenhart and Workman, 2007).
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APPENDIX A
The following gives additional explanation to the work given in Lenhart and
Workman Chapter 1 pages 8-12.
Our optimal control problem is given with bounded state and control
variables to be mapped into R,
x : [a, b]→ R state variables
u : [a, b]→ R control variable.
Our goal is to maximize or minimize our functional J [u] with respect to u,
J [u] =
∫ t1
t0
f(t, x(t), u(t))dt.
We want to choose u to maximize or minimize J [u] such that
x′(t) = g(t, x(t), u(t))
x(t0) = x0
x(t1) is free.
Our technique to solve the problem is to use our necessary condition: if u∗(t), x∗(t)
optimal values exist then the following conditions hold:
H(t, x, u, λ) = f(t, x, u) + λ ∗ g(t, x, u)
= integrand + adjoint ∗ RHS of DE
∂H
∂u
= 0 at u∗ ⇒ fu + λgu = 0 (optimality condition),
λ′ = −∂H
∂x
⇒ λ′ = −(fx + λgx) (adjoint equation),
λ(t1) = 0 (transversality condition).
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We are given the dynamics of the state equation:
x′ = g(t, x, u) =
∂H
∂λ
, x(t0) = x0.
Assuming the optimal control exists then J [u] ≤ J [u∗] <∞ (for a maximization
problem). Let h(t) be a piecewise continous variation function and  ∈ R a constant.
Then,
u(t) = u∗(t) + h(t)
is another piecewise continuous control. Let x be the state corresponding to the
control u, namely, x satisfies
d
dt
x(t) = g(t, x(t), u(t))
wherever u is continuous. We have the following four properties:
1. lim
→0
u(t) = u∗(t)∀t because u(t) = u∗(t) + h(t) and h(t) goes to 0.
2.
∂u(t)
∂
|=0 = h(t).
3. lim
→0
x(t) = x∗(t)∀t because of our assumptions on g.
4.
∂x(t)
∂
|=0 exists for each value of t.
The objective functional at u is
J [u] =
∫ t1
t0
f(t, x(t), u(t))dt.
The adjoint function (λ) appends the differential equation to the integrand of the
objective functional. (This is like adding zero to an equation to make the equation
work). Let λ(t) be a piecewise differentiable function on [t0, t1]. By the
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Fundamental Theorem of Calculus
∫ t1
t0
d
dt
[λ(t)x(t)]dt = λ(t1)x
(t1)− λ(t0)x(t0),
which implies ∫ t1
t0
d
dt
[λ(t)x(t)]dt− λ(t1)x(t1) + λ(t0)x0 = 0
because x0 = x
(t0). Adding this 0 expression to our J [u
] gives
J [u] =
∫ t1
t0
[f(t, x(t), u(t)) +
d
dt
(λ(t)x(t))]dt+ λ(t0)x0 − λ(t1)x(t1)
=
∫ t1
t0
[f(t, x(t), u(t)) + λ(t)
d
dt
x(t) + xλ′(t)]dt+ λ(t0)x0 − λ(t1)x(t1)
=
∫ t1
t0
[f(t, x(t), u(t)) + λ(t)g(t, x(t), u(t)) + xλ′(t)]dt+ λ(t0)x0 − λ(t1)x(t1).
Also, suppose  = f(u) then
0 =
d
du
J [u] =
d
du

dJ
d
.
Then
d
du
J [u] is maximized when
dJ
d
∣∣∣
=0
and when  = 0, u(t) = u∗(t). So we have
0 =
∂
∂
J [u]
∣∣∣
=0
=
∫ t1
t0
∂
∂
[f(t, x(t), u(t)) + λ′(t)x(t) + λ(t)g(t, x(t), u(t)dt]
∣∣∣
=0
− ∂
∂
λ(t1)x
(t1)
∣∣∣
=0
+
∂
∂
λ(t0)x0
∣∣∣
=0
=
∫ t1
t0
[
fx
∂
∂
x + fu
∂
∂
u + λ(t)(gx
∂
∂
x + gu
∂
∂
u) + λ′(t)
∂
∂
x
] ∣∣∣
=0
dt
−λ(t1) ∂
∂
x(t1)
∣∣∣
=0
.
Note: If  = 0, then
d
dx
f(t, x, u) =
d
d
(f, x∗, u∗). Then rearranging the terms gives,
0 =
∫ t1
t0
[
(fx + λ(t)gx + λ
′(t))
∂
∂
x(t)|=0 + (fu + λ(t)gu)h(t)
]
dt− λ(t1) ∂
∂
x(t1)
∣∣∣
=0
.
We want to choose our adjoint function to simplify the above equation by making
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the coefficients of
∂
∂
x(t)
∣∣∣
=0
vanish. Thus, we choose the adjoint function λ(t) to
satisfy
λ′(t) = −[fx(t, x∗(t), u∗(t)) + λ(t)gx(t, x∗(t), u∗(t))] (adjoint equation),
and the boundary condition
λ(t1) = 0 (transversality condition).
So our equation reduces to
0 =
∫ t1
t0
(fu(t, x
∗(t), u∗(t)) + λ(t)gu(t, x∗(t), u∗(t)))h(t)dt.
This holds for any piecewise continuous variation function h(t), so it holds for
h(t) = fu(t, x
∗(t), u∗(t)) + λ(t)gu(t, x∗(t), u∗(t)).
In this case we have
0 =
∫ t1
t0
(fu(t, x
∗(t), u∗(t)) + λ(t)gu(t, x∗(t), u∗(t)))
2 dt,
which implies our optimality condition
fu(t, x
∗(t), u∗(t)) + λ(t)gu(t, x∗(t), u∗(t) = 0 for all t0 ≤ t ≤ t1.
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APPENDIX B
Extra Linear Test Problem
In order to solve our linear control numerically, we created a simpler test problem
that could be solved analytically to test our coding and to help us learn about any
potential pitfalls. We wanted this problem to be similar to the index one
J [u(t)] =
∫ t1
0
[b(t) + cu(t)] dt so we formulated a linear problem similar to our
non-linear test problem:
min
−0.5≤u≤0.5
∫ 1
0
[x2 + u]du
subject to: 
x′1 = x2
x′2 = x1 + u
λ′1 = −λ2
λ′2 = −λ1 − 1.
Our Hamiltonian for this problem is H = x2 + u+ λ1x2 + λ2(x1 + u). Our
partial derivative of H with respect to u is
∂H
∂u
= 1 + λ2 so we define our switching
function ψ to be ψ = 1 + λ2.
If ψ = 0 on some interval then ψ = 1 + λ2 = 0 which means that
λ2 = −1→ λ′1 = 1 and λ′2 = 0 = −λ1 − 1→ λ1 = 1. This causes a contradiction as
λ1 = 1 and λ
′
1 = 1 cannot both simultaneously be true. Thus ψ 6= 0 for any time
interval. So u∗ only admits a bang-bang solution.
Thus, we have
 u
∗ = −0.5⇔ ψ > 0⇔ 1 + λ2 > 0⇔ λ2 > −1
u∗ = 0.5⇔ ψ < 0⇔ 1 + λ2 < 0⇔ λ2 < −1.
(15)
Notice that λ′′1 = −λ′2 so λ′′1 = λ1 + 1 and λ1(1) = 0, λ′1(1) = 0. Let y = λ1 + 1. Then
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y′′ = y with y(1) = 1, y′(1) = 0. So we have
y(t) = c1 ∗ et + c2 ∗ e−t
y′(1) = c1 ∗ e− c2 ∗ e−1 = 0
y′(1) = c1 ∗ e2 − c2 = 0
⇒ c2 = c1 ∗ e2
y(t) = c1(e
t + e2−t)
y(1) = c1(e+ e) = 1⇒ c1 = .5e−1
y(t) =
1
2
(et−1 + e1−t)
λ1(t) =
1
2
(et−1 + e1−t)− 1
−λ2(t) = λ′1(t) =
1
2
(et−1 − e1−t)
λ2(t) = −1
2
(et−1 + e1−t).
(16)
Then we solved for when λ2(t) < −1 (15):
λ2(t) = − sinh (t− 1) < −1
λ2(t) = sinh (t− 1) > 1
t− 1 > sinh−1 (1)
t > 1 + sinh−1 (1) = 1 + ln(1 +
√
2) ≈ 1.8814.
(17)
Similarly we solved for when λ2 > 1:
λ2(t) = − sinh (t− 1) > −1
sinh (t− 1) < 1
t < 1 + sinh−1 (1) = 1 + ln (1 +
√
2) ≈ 1.8814.
(18)
Thus u∗ = −0.5 for 0 ≤ t ≤ 1.8814. In order to find x∗1(t) and x∗2(t) we will
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substitute in our value for the optimal control, u∗ and solve.

x′1 = x2
x′2 = x1 − 0.5
x1(0) = 0, x2(0) = 0
(19)
Similar to what we did with λ1 above, we have x
′′
1 = x1 − 0.5 and x′1(0) = 0. Let
y = x1 − 0.5. Then y′′ = y, y(0) = −0.5, y′(0) = 0. Solving yields
y(t) = d1 ∗ et + d2 ∗ e−t
y′(0) = d1 − d2 = 0→ d1 = d2
y(0) = d1 + d2 = 2d1 = −0.5
y(t) = −0.5 ∗ e
t + e−t
2
= −0.5 ∗ cosh (t).
Thus, we have  x1(t) = 0.5− 0.5 ∗ cosh (t)x2(t) = −0.5 ∗ sinh (t).
Figures (21) and (22) show that our analytical and numerical solutions match,
because the two solutions overlap.
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Figure 21: This figure shows that our values for x and λ from our analytical and
numerical solutions match, because the two solutions overlap.
Figure 22: This figure shows that our values for u from our analytical and numerical
solutions match, because the two solutions overlap.
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APPENDIX C
Figures 23-27 give the basic code that we used for the non-linear case, where
u is updated using the average of the old and new u values. This has been adjusted
to form our other cases (different updates of u and our linear case). Some of these
adjustments have been given previously, (see Figures (6), (11), and (17)).
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Figure 23: Basic Code Part 1
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Figure 24: Basic Code Part 2
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Figure 25: Basic Code Part 3
65
Figure 26: Basic Code Part 4
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Figure 27: Basic Code Part 5
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